Revive Therapeutics Ltd. (CSE:RVV)
Canada flag Canada · Delayed Price · Currency is CAD
0.0150
+0.0050 (33.33%)
Apr 2, 2025, 12:40 PM EST

Revive Therapeutics Cash Flow Statement

Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
Net Income
-5.29-5.62-6.32-17.81-20.12-5.38
Upgrade
Depreciation & Amortization
000000.03
Upgrade
Asset Writedown & Restructuring Costs
2.342.340.78---
Upgrade
Loss (Gain) From Sale of Investments
0.060.050.09--0.180.45
Upgrade
Stock-Based Compensation
0.10.14-1.048.571.19
Upgrade
Other Operating Activities
-0.01-0.010.180.172.721.7
Upgrade
Change in Accounts Payable
0.170.04-0.763.580.210.04
Upgrade
Change in Other Net Operating Assets
0.04-0.230.01-0.030.5-0.55
Upgrade
Operating Cash Flow
-2.6-3.29-6.03-13.06-8.31-2.52
Upgrade
Sale (Purchase) of Intangibles
-----3-
Upgrade
Investment in Securities
-0.03---0.280.14
Upgrade
Investing Cash Flow
-0.03----2.720.14
Upgrade
Short-Term Debt Issued
-----0.21
Upgrade
Long-Term Debt Issued
----0.020.04
Upgrade
Total Debt Issued
----0.020.25
Upgrade
Long-Term Debt Repaid
--0.19-0.15-0.15-0.15-0.14
Upgrade
Net Debt Issued (Repaid)
-0.14-0.19-0.15-0.15-0.130.11
Upgrade
Issuance of Common Stock
2.12.14.590.3828.673.39
Upgrade
Other Financing Activities
0.020.07-0.240.15-2.3-0.22
Upgrade
Financing Cash Flow
1.981.984.20.3826.243.28
Upgrade
Net Cash Flow
-0.65-1.31-1.83-12.6815.220.91
Upgrade
Free Cash Flow
-2.6-3.29-6.03-13.06-8.31-2.52
Upgrade
Free Cash Flow Per Share
-0.01-0.01-0.02-0.04-0.03-0.02
Upgrade
Levered Free Cash Flow
-1.47-2.04-4.25-6.66-5.4-1.78
Upgrade
Unlevered Free Cash Flow
-1.47-2.02-4.23-6.62-5.35-1.73
Upgrade
Change in Net Working Capital
-0.260.110.77-3.5-0.690.64
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.